A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT06238622 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1700

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis
Progressive Pulmonary Fibrosis

Interventions

DRUG: Nerandomilast

Sponsor

Boehringer Ingelheim